VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRVA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PRVAPrivia Health Group, Inc.
$27.23$3.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

PRVA logoPrivia Health Group, Inc.(PRVA)Earnings, Financials & Key Ratios

PRVA•NASDAQ
$27.23
151.3× P/E·Price updated Jul 7, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryCare Delivery Networks and Value-Based Care
AboutPrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.Show more
  • Revenue$2.12B+22.3%
  • EBITDA$44M+82.0%
  • Net Income$23M+59.3%
  • EPS (Diluted)0.18+63.6%
  • Gross Margin9.87%-3.1%
  • EBITDA Margin2.08%+48.9%
  • Operating Margin1.61%+64.9%
  • Net Margin1.08%+30.3%
  • ROE3.11%+39.5%

PRVA Price & Volume

Privia Health Group, Inc. (PRVA) stock price & volume — 10-year historical chart

Loading chart...

Accelerating Revenue Growth Faces Structural Margin Constraints

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Accelerating
Profitability:Strained
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Regulatory reimbursement model shifts

Key Thesis Takeaways

  • Privia Health Group is successfully scaling its provider network, evidenced by a 25.8% year-over-year revenue growth rate in 2026Q1, yet the company struggles to demonstrate meaningful operating leverage as corporate overhead scales alongside top-line expansion.
  • While the balance sheet remains conservative with a debt-to-equity ratio of 0.01, the reliance on inorganic growth through acquisitions—which pushed goodwill to $209.8 million—introduces integration risks.
  • Investors should monitor the volatility in cash collections, as evidenced by the $80.9 million working capital outflow in 2026Q1, which continues to obscure the company's underlying profitability and free cash flow generation.

Verdict Logic

while the company is achieving rapid top-line growth, the current P/E ratio of 142.06 and the lack of consistent operating leverage suggest that the market may be overvaluing the platform before it proves sustainable profitability.

PRVA Growth Metrics

Privia Health Group, Inc. (PRVA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years21.04%
3 Years16.1%
TTM24.72%

Profit CAGR

10 Years-
5 Years-6.01%
3 Years-
TTM39.32%

EPS CAGR

10 Years-
5 Years-9.71%
3 Years-
TTM34.46%

Return on Capital

10 Years-3.74%
5 Years-11.41%
3 Years3.61%
Last Year4.6%

PRVA Recent Earnings

Privia Health Group, Inc. (PRVA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 1/12 qtrs (8%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.02-75.0%
$0.08
Rev
$604M+7.6%
$561M
Q1 2026
Feb 26, 2026
Metric
Actual
Est
EPS
$0.07+75.0%
$0.04
Rev
$541M+4.8%
$516M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.05-16.7%
$0.06
Rev
$580M+12.4%
$517M
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.02-60.0%
$0.05
Rev
$521M+7.3%
$486M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.02vs $0.08-75.0%
$604Mvs $561M+7.6%
Q1 2026Feb 26, 2026
$0.07vs $0.04+75.0%
$541Mvs $516M+4.8%
Q4 2025Nov 6, 2025
$0.05vs $0.06-16.7%
$580Mvs $517M+12.4%
Q3 2025Aug 7, 2025
$0.02vs $0.05-60.0%
$521Mvs $486M+7.3%
Based on last 12 quarters of dataView full earnings history →

Latest PRVA News

Recent stock market news and headlines for Privia Health Group, Inc. (PRVA)

GlobeNewsWire·1 day ago
Privia Health to Report Second Quarter 2026 Results on Thursday, August 6

ARLINGTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2026 before market open on Thursday, August 6, 2026.

Peers Comparison

Key metrics vs top competitors for Privia Health Group, Inc. (PRVA)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
PRVA logoPRVAPrivia Health Group, Inc.Current
$27.23$3.43B151.2822.26%1.08%3.11%—
AGIO logoAGIOAgios Pharmaceuticals, Inc.
$44.01$2.62B-6.1848.03%-639.84%-34.11%—
CNC logoCNCCentene Corporation
$66.12$32.65B-4.8519.44%-3.25%-28.6%—
ALHC logoALHCAlignment Healthcare, Inc.
$24.05$4.91B-6500.0046.06%0.47%11.5%—
OSCR logoOSCROscar Health, Inc.
$31.12$8.07B-18.4127.5%-0.3%-3.26%—
DOCS logoDOCSDoximity, Inc.
$22.74$4.25B23.2013.05%30.4%19.36%—

Compare PRVA vs Peers

Privia Health Group, Inc. (PRVA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AGIO

Most directly comparable listed peer for PRVA.

Scale Benchmark

vs UNH

Larger-name benchmark to compare PRVA against a more recognizable public peer.

Peer Set

Compare Top 5

vs AGIO, CNC, ALHC, OSCR

PRVA SEC Filings & Documents

Privia Health Group, Inc. (PRVA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Dec 8, 2025·SEC

10-K Annual Reports

3
FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

Get notified when PRVA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PRVA Frequently Asked Questions

Privia Health Group, Inc. (PRVA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Privia Health Group, Inc.'s revenue?

Privia Health Group, Inc. (PRVA) reported $2.25B in revenue for fiscal year 2025. This represents a 242% increase from $657.6M in 2018.

How fast is Privia Health Group, Inc. growing?

Privia Health Group, Inc. (PRVA) grew revenue by 22.3% over the past year. This is strong growth.

Is PRVA profitable?

Yes, Privia Health Group, Inc. (PRVA) is profitable, generating $21.8M in net income for fiscal year 2025 (1.1% net margin).

Dividend & Returns
What is PRVA's return on equity?

Privia Health Group, Inc. (PRVA) has a return on equity (ROE) of 3.1%. This is below average, suggesting room for improvement.

What is Privia Health Group, Inc.'s free cash flow?

Privia Health Group, Inc. (PRVA) generated $136.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in PRVA back in 2018?

Total return calculator · dividends reinvested · 8+ years of data

See returns →